BioVentureVoiCes
@BioVentureVoiCe
Followers
155
Following
40
Media
8
Statuses
41
Joined September 2024
BioVenture VoiCes is a new video podcast on @BiotechTVHQ that will feature leading VC investors to discuss heathcare venture investing from an insider's perspective to dig deeper into best practices, strategies, and emerging trends and shifting landscape of healthcare technology!
New Program Announcement: BioVenture VoiCes with Chris Garabedian. Today we welcome a regular new program on BiotechTV. @cngarabedian will host the top venture investors in biotech to get their insights on the sector. Watch here in the future: https://t.co/Hwb3nbDZyh
0
1
2
Listen to Episode 29 of @BioVentureVoiCe video podcast w/ @DavidBerry26 of @averincapital and hear him describe his philosophy of creating innovative startups, which he did for @FlagshipPioneer for over 15 years before starting his own VC with his brother to invest at the nexus
biotechtv.com
He describes his early life and education, 18 years of company building at Flagship Pioneering, founding Averin (previously called Bedford Bridge) with his brother, and investing at the intersection...
๐๐ข๐จ๐๐๐ง๐ญ๐ฎ๐ซ๐ ๐๐จ๐ข๐๐๐ฌ: @averincapital Managing Partner @DavidBerry26 on investing at the intersection of healthcare and technology. Full video: https://t.co/3F24pD00CM
0
2
7
Our next guest (Ep.29) on @BioVentureVoiCe video podcast will be @DavidBerry26 of @averincapital ( https://t.co/twyP72uTQe), who shares his early experiences and 15 years at @FlagshipPioneer with company creation before starting his own VC firm with his brother to invest at the
0
1
4
Listen to Episode 28 of @BioVentureVoiCe video podcast w/ Clay Thorp of Hatteras Venture Partners ( https://t.co/K7483i6Ma7) and hear him describe his investing history over 25 years and 100 companies born out of his connections within the North Carolina life sciences ecosystem.
๐๐ข๐จ๐๐๐ง๐ญ๐ฎ๐ซ๐ ๐๐จ๐ข๐๐๐ฌ: Hatteras Venture Partners' Clay Thorp on investing in the strengths of the North Carolina life sciences ecosystem and beyond. Full video: https://t.co/ake1IzBT4s
1
1
9
Our next guest (Ep.28) on @BioVentureVoiCe video podcast will be Clay Thorp, Co-founder and General Partner of Hatteras Venture Partners ( https://t.co/v5Uoo3oFx0), who shares the evoluation of Hatteras from a first fund of $3mm to the closing of Fund VII this year and celebrating
0
1
4
Listen to Episode 27 of @BioVentureVoiCe video podcast w Jay Lichter of Avalon Bioventures ( https://t.co/X2geAeT58o) and hear him describe his decades long career incubating and leading biotech startups for Avalon Ventures and the launch of Avalon's first biotech-only fund in
avalonbioventures.com
Avalon BioVentures is a San Diego venture fund with a team of seasoned entrepreneurs and operators that work side-by-side with biotech founders to translate cutting-edge science into breakthrough...
๐๐ข๐จ๐๐๐ง๐ญ๐ฎ๐ซ๐ ๐๐จ๐ข๐๐๐ฌ: Jay Lichter recounts the numerous companies he has either operated or funded in his career, leading to his work today at Avalon Bioventures. Full video: https://t.co/Hwb3nbDZyh
0
1
10
Our next guest (Ep.27) on @BioVentureVoiCe video podcast will be Jay Lichter, Managing Director of Avalon Bioventures ( https://t.co/X2geAeTCXW), the first biotech-focused fund out of Avalon Ventures, where he continues his decades-long efforts in company incubation with a
0
1
4
Listen to Episode 26 of @BioVentureVoiCe video podcast w/ Corey Goodman of venBio ( https://t.co/CxN1CDK1Kr) and hear him describe how his long career across academic research, serial entrepreneurship and as a public company CEO (Renovis) shaped venBioโs investment strategy across
๐๐ข๐จ๐๐๐ง๐ญ๐ฎ๐ซ๐ ๐๐จ๐ข๐๐๐ฌ: venBio's Corey Goodman shares learnings from his career in biotech, including working in academia, biotech, pharma, and as a venture capital investor. Full video: https://t.co/4WOnZc36QF
0
1
3
Our next guest (Ep.26) on @BioVentureVoiCes will be Corey Goodman, Co-founder and Managing Partner of venBio ( https://t.co/CxN1CDK1Kr) where he has led portfolio investments over 15 years, across 5 funds with many successful exits and FDA-approved products. He's had a remarkable
1
1
23
Listen to Episode 25 of @BioVentureVoiCe video podcast w/ Bruce Booth (@LifeSciVC) and hear him describe @atlasventure's evolution into a focused strategy on biotech investing and company creation and into Opportunity Funds to continue to bet on Atlas companies with continued
biotechtv.com
Bruce Booth discusses his education and early career, the structure of Atlas and the types of investments it makes, investing in assets vs platforms, and more.Bruce Booth BioVenture VoiCesChaptersE...
๐๐ข๐จ๐๐๐ง๐ญ๐ฎ๐ซ๐ ๐๐จ๐ข๐๐๐ฌ: @atlasventure's @LifeSciVC discusses his education and early career, the structure of Atlas and the types of investments it makes, investing in assets vs platforms, and more. Full video: https://t.co/tc0CzezmWo
0
1
8
Our next guest (Ep.25) on @BioVentureVoiCe will be Bruce Booth (@LifeSciVC), Partner at @atlasventure where he has been leading biotech investments and company creation for 20 years. Bruce describes how the firm has evolved from it's early days as a dual-sector (tech and life
3
3
36
Listen to Episode 24 of @BioVentureVoiCe video podcast w/ Srini Akkaraju of @samsaracapital and hear how his early involvement with SeaGen shaped his view on balancing opportunism with a long-term view on value creation. The full video is here on @BiotechTV (and also on Spotify
biotechtv.com
The Founder & Managing Partner of Samsara Biocapital, Dr. Akkaraju describes his early move from Standford to industry and various investment firms he worked for before founding Samsara in 2016. He...
๐๐ข๐จ๐๐๐ง๐ญ๐ฎ๐ซ๐ ๐๐จ๐ข๐๐๐ฌ: @samsaracapital's Srini Akkaraju on investing in all stages of life sciences companies and why he believes patience is a virtue. Full video: https://t.co/vh0tCbxfcA
0
4
27
Our next guest (Ep.24) on @BioVentureVoiCe will be Srini Akkaraju, Founder and Managing General Partner at Samsara BioCapital (@samsaracapital) where he leads a multi-stage investment strategy from launching companies as first investor to PIPEs. Srini describes how his early
0
4
36
๐
๐ซ๐จ๐ฆ ๐๐๐ฌ๐ญ๐๐ซ๐๐๐ฒ: @vintweeta describes to @cngarabedian what she believes separates @a16z from other VCs in early stage investing. See the full interview: https://t.co/c62V9POCkQ
0
2
5
Our next guest (Ep.23) on @BioVentureVoiCe will be Vineeta Agarwala @vintweeta, General Partner at @a16z where she leads investments across biotech and healthcare. She shares the fund's overall strategy and the unique collaboration with Lilly on a separate $500mm venture fund,
1
1
6
Listen to Episode 23 of @BioVentureVoiCe video podcast w/ Vineeta Agarwala (@vintweeta) of @a16z and hear about the unique fund with Lilly and how the firm is viewing their investment strategy across heatlhcare. Vineeta shares how her early influences and experiences as an
biotechtv.com
Still a practicing physician today, Vineeta Agarwala describes her educational background and early career, including experiences at the Broad Institute, Flatiron Health, and GV (Google Ventures)....
๐๐ข๐จ๐๐๐ง๐ญ๐ฎ๐ซ๐ ๐๐จ๐ข๐๐๐ฌ: @vintweeta shares her background, describes @a16z's investment philosophy of "providing more than just a check," and a recent up to $500M fund partnered with Lilly. Full video: https://t.co/c62V9POCkQ
1
1
11
Listen to Episode 22 of @BioVentureVoiCe video podcast w/ Glenn Rockman of @adjcap and hear about Adjuvant's focus on global health, neglected and infectious disease investing and the case for generating returns for shareholders with a venture philanthropy and impact investing
biotechtv.com
Glenn Rockman describes the introduction to impact investing he gained from working for J.P. Morgan and along with the Gates Foundation on the Global Health Investment Fund, and how the idea of...
๐๐ข๐จ๐๐๐ง๐ญ๐ฎ๐ซ๐ ๐๐จ๐ข๐๐๐ฌ: @adjcap's Glenn Rockman discusses the firm's method of impact investing that is designed to accelerate and broaden the development of public health technologies. Full video: https://t.co/PQLNYyAsSJ
0
2
10
Listen to Episode 20 of @BioVentureVoiCe video podcast w/ @lindyfishburne of @breakout_vc and hear about her journey from the late 90s tech/genomics bubble to seeing the convergence o tech and life sciences and establishing Breakout Labs with The Thiel Foundation to establishment
biotechtv.com
Lindy Fishburne describes her educational background and career, and transitioning from the philanthropic Breakout Labs within the Thiel Foundation to Breakout Ventures, a traditional venture firm...
๐๐ข๐จ๐๐๐ง๐ญ๐ฎ๐ซ๐ ๐๐จ๐ข๐๐๐ฌ: @breakout_vc's @lindyfishburne on transitioning from the philanthropic Breakout Labs within the Thiel Foundation to Breakout Ventures, a traditional venture firm that has a diverse set of limited partners. Full video: https://t.co/5kBqkXKCER
2
2
9
Our next guest (Ep.20) on BioVenture VoiCes will be @lindyfishburne, co-founder and Managing Partner of @breakout_vc. She describes her early experiences at the dawn of the tech / genomics revolution and helping bridge the gap between a good life sciences startup ideas to an
0
2
8
Listen to Episode 19 of @BioVentureVoiCe video podcast w/ the legendary @drcwestphal of @LongwoodFund and hear about his long career in company creation and venture investing that has led to 20+ FDA Approved products and his history and connection w/ many biotech luminaries! The
biotechtv.com
The BioVenture VoiCes podcast with Chris Garabedian
๐๐ข๐จ๐๐๐ง๐ญ๐ฎ๐ซ๐ ๐๐จ๐ข๐๐๐ฌ: @LongwoodFund's @drcwestphal on founding companies, venture investing, the current environment in biotech, and his love of the Boston ecosystem. Full video: https://t.co/HH1u6Vi4VB
2
6
20
Our next guest (Ep.19) on BioVenture VoiCes will be legendary @drcwestphal, Co-founder and General Partner of @LongwoodFund. He describes his journey from his Harvard MD-PhD to early experiences at @PolarisVC and GSK/SR One building successful biotech companies (incl. @Alnylam)
0
5
16